Sangamo and CHDI partners to develop a therapeutic for Huntington's disease (HD) based on Sangamo's zinc finger DNA-binding protein (ZFP) technology

CHDI Foundation Inc.

U.S. / Non-Profit or Major Disease Foundation

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sangamo BioSciences Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced